Login
From:
STAT
(Uncensored)
subscribe
STAT+: Novartis to buy RNA-focused Avidity in $12 billion deal
https://www.statnews.com/2025/10/26/novartis-acquire-avidity-rna-neuromuscular-diseases/?utm_campaign=rss
links
backlinks
Tagged with:
biotechnology
biotech
pharmaceuticals
drug development
stat+
Novartis is buying Avidity Biosciences for $12 billion, picking up RNA-based medicines for neuromuscular diseases as it seeks to grow its pipeline.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
